It suppresses ERK phosphorylation and KRAS-driven cancer cell proliferation in vitro and tumor growth in vivo.310 In contrary to NS1 monobody, 12VC1 binds to an interface composing of switch I and switch II. Here, KRAS is linked to neoplasm.